Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Guggenheim Downgrades IDEXX Laboratories to Neutral

Guggenheim analyst David Westenberg downgrades IDEXX Laboratories (NASDAQ:IDXX) from Buy to Neutral.

Guggenheim analyst David Westenberg downgrades IDEXX Laboratories (NASDAQ:IDXX) from Buy to Neutral.

Total
0
Shares